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Abstract 
Several autoimmune diseases are known to develop in postmenopausal women. 
However, the mechanism by which estrogen deficiency influences autoimmunity is 
unknown. Aromatase is a converting enzyme from androgens to estrogens. In the 
present study, we used female aromatase gene knockout (ArKO) mice as a model of 
estrogen deficiency to investigate the molecular mechanism that underlies the onset and 
development of autoimmunity. Histological analyses showed that inflammatory lesions 
in the lacrimal and salivary glands of ArKO mice increased with age. Adoptive transfer 
of spleen cells or bone marrow cells from ArKO mice into recombination activating 
gene 2 knockout mice failed to induce the autoimmune lesions. Expression of mRNA 
encoding proinflammatory cytokines and monocyte chemotactic protein-1 (MCP-1) 
increased in white adipose tissue (WAT) of ArKO mice and was significantly higher 
than that in wild-type mice. Moreover, an increased number of inflammatory M-1 
macrophage was observed in WAT of ArKO mice. A significantly increased MCP-1 
mRNA expression of the salivary gland tissue in ArKO was found together with 
adiposity. Furthermore, the autoimmune lesions in a murine model of Sjögren’s 
syndrome (SS) were exacerbated by administration of an aromatase inhibitor. These 
results suggest that aromatase may play in a key role in the pathogenesis of SS-like 
lesions by controlling the target organ and adipose tissue-associated macrophage. 
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Introduction 
Autoimmune disease is caused by multiple factors. One of them is the disruption of 
self-tolerance.1,2 Several autoimmune diseases such as rheumatoid arthritis or Sjögren’s 
syndrome (SS) occur in postmenopausal women. Sex steroid hormones such as 
estrogens may influence the onset or development of autoimmune diseases through an 
unknown mechanism. 3,4 
  SS is an autoimmune disease characterized by a 9:1 ratio of women to men, and 
almost all SS patients are postmenopausal women.5 SS targets exocrine glands such as 
the salivary and lacrimal glands, causing patients with SS to experience dryness of the 
mouth and dry eyes.6 We demonstrated that estrogen deficiency caused by ovariectomy 
exacerbates autoimmune lesions in a murine model of SS.7 Further, we reported that 
retinoblastoma-associated protein 48 (RbAp48) induces tissue-specific apoptosis in the 
salivary and lacrimal glands of mice depending on the level of estrogen deficiency.8 
Moreover, we observed that transgenic expression of RbAp48 in exocrine glands causes 
the development of autoimmune exocrinopathy, resembling SS.9 Although 
postmenopausal estrogen deficiency triggers the breakdown of immune tolerance and 
induces autoimmune disease, multiple direct or indirect factors that are affected by the 
change in estrogen level impede efforts to understand the molecular mechanisms 
involved in autoimmunity. 
  Estrogens are synthesized from androgens by aromatase, a key step in the 
biosynthesis of estrogens. Studies on aromatase knockout (ArKO) mice show that 
aromatase/estrogens plays key roles in controlling sex-specific morphological, 
neuroendocrinological, and behavioral differences in the brain.10−12 Further, ArKO mice 
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develop marked abdominal adiposity, suggesting that aromatase/estrogens controls the 
adipose phenotype through the regulation of lipid metabolism.13,14 Moreover, ArKO 
mice spontaneously develop an autoimmune disease, resembling age-associated SS 
lesions through B cell hyperplasia and autoantibody production.15 In addition, increased 
number of peripheral blood cell and bone marrow cell, and inflammatory renal lesion 
are observed in ArKO mice.15 However, the molecular mechanism responsible for the 
onset of autoimmunity in exocrine glands through aromatase is unknown. In particular, 
the relationship between aromatase activity and the function of immune cells, besides B 
cells, in the onset or development of autoimmune disease must be determined to 
understand the dysfunction of the immune system in postmenopausal women. 
     In the present study, we investigated the association of the pathogenesis of 
autoimmune disease with postmenopausal changes induced by estrogen deficiency. 
Further, we attempted to define the molecular mechanism that accounts for the 
breakdown of peripheral immune tolerance with the goal of establishing a new 
therapeutic strategy to treat gender-specific autoimmune diseases.  
 
Materials and Methods 
Mice 
Female C57BL/6 (B6) mice were purchased from the Japan SLC Laboratory (Shizuoka, 
Japan). ArKO mice were obtained from RIKEN BioResource Center (Tsukuba, Japan). 
Female ArKO were used for this study. Female Rag2KO mice were obtained from 
Taconic. Female NFS/N mice carrying mutant sld were reared in our specific 
pathogen-free mouse colony and given food and water ad libitum. Thymectomy was 
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performed on day three after birth of the NFS/sld mice. All mice were bred in the 
animal facility of the University of Tokushima under specific pathogen-free conditions. 
The experiments were approved by the animal ethics board of the University of 
Tokushima. 
 
Administration of Aromatase Inhibitor 
The aromatase inhibitor (AI) exemestane (Sigma-Aldrich, St. Louis, MO) was prepared 
as an aqueous suspension in 0.5% carboxymethylcellulose (CMC) (Dai-Ichi Chemical 
Industries, Tokyo, Japan). Intraperitoneal injection of B6 mice (8 weeks old) with 200 
µl CMC, containing AI (0, 50, and 200 µg/mouse), was administered. For female 
Tx-NFS/sld mice, AI in CMC was injected every day till 4–8 weeks of age. 
 
Histology 
All organs were removed from the mice, fixed with 4% phosphate-buffered 
formaldehyde (pH 7.2), and prepared for histological examination. Formalin-fixed 
tissue sections were subjected to hematoxylin-eosin (HE) staining, and three 
pathologists independently evaluated the histology without being informed of the 
condition of each mouse. Histological grading was performed according to a previously 
published method.16 In brief, the inflammatory lesions of lacrimal and salivary glands 
were evaluated as followed: slight, no change or slight lymphoid cell infiltration; 
moderate, lymphoid cell infiltration; and severe, marked lymphoid cell infiltration with 
tissue destruction. 
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Adoptive cell transfer 
Spleen cells (5 × 106) from female WT and ArKO mice (10 weeks of age) were 
intravenously transferred into female Rag2KO mice (8 weeks of age). In addition, bone 
marrow cells (5 × 106) from WT and ArKO mice were intravenously transferred into 
irradiated (8 Gy) Rag2KO mice. Twelve weeks after transfer, the pathology of all 
organs was analyzed.  
 
Flow cytometry 
Antibodies against CD4, CD8, CD11c, F4/80, CCR2, and CD206 were conjugated as 
required to FITC, PE, allophycocyanin–peridin chlorophyll protein, PE-Cy5.5, PE-Cy7, 
or allophycocyanin–Cy7 (eBioscience, San Diego, CA). A FACScanto flow cytometer 
(BD Biosciences, Franklin Lakes, NJ) was used to determine the cell populations, and 
the data were analyzed using FlowJo FACS Analysis software (Tree Star, Ashland, OR). 
 
ELISAs 
The α-fodrin (JS-1),16 SS-A/Ro (Immunovision, Springdale, AR), SS-B/La 
(Immunovision), or ss-DNA (Immunovision)-specific antibodies in sera from mice were 
measured using ELISAs as previously described.16 In brief, the antibodies were added 
to microtiter wells at a concentration of 1 µg/ml of PBS. Nonspecific sites were 
absorbed with 1% BSA in PBS. After the plates were washed, diluted sera were added. 
Horseradish peroxidase-conjugated anti-mouse IgG (heavy and light chains; Vector 
Burlingame, CA) was added as the secondary antibody, and o-phenylenediamine (OPD; 
Sigma-Aldrich) buffer was added. Antibodies were measured with an microplate reader 
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(Bio-Rad Laboratories, Richmond, CA). 
 
Quantitative RT-PCR 
Total RNA was extracted from WAT, spleen, salivary glands, and liver using Isogen 
(Wako Pure Chemical Industries, Osaka, Japan) and subsequently reverse-transcribed. 
The levels of mRNAs encoding F4/80, MCP-1, TLR-4, NF-κB, IL-6, IL-1β, IFN-γ, 
TNF-α, IL-10, TGF-β, and β-actin were determined using a PTC-200 DNA Engine 
Cycler (Bio-Rad Laboratories) with SYBR Premix Ex Taq (Takara Bio, Shiga, Japan). 
The primer sequences used were as follows: F4/80, forward, 
5′-CTTTGGCTATGGGCTTCCAGTC-3′, and reverse, 
5′-GCAAGGAGGACAGAGTTTATCGTG -3′; MCP-1, forward, 
5′-CTGGATCGGAACCAAATGAG -3′, and reverse, 
5′-TGAGGTGGTTGTGGAAAAGG -3′; TLR-4: forward, 
5′-CAGTGGTCAGTGTGATTGTGG -3′ and reverse, 
5′-TTCCTGGATGATGATGTTGGCAGC-3′; NF-κB: forward, 
5′-ATGGCAGACGATGATCCCTA -3′ and reverse, 
5′-TAGGCAAGGTCAGAATGCAC-3′; IL-1β: forward, 
5′-TGATGAGAATGACCTGTTCT-3′, and reverse, 
5′-CTTCTTCAAAGATGAAGGAAA-3′; IL-6, forward, 
5′-GCTACCAAACTGGATATAATCAGGA-3′, and reverse, 
5′-CCAGGTAGCTATGGTACTCCAGAA-3′; IFN-γ, forward, 
5′-AGCGGCTGACTGAACTCAGATTGTAG -3′, and reverse, 
5′-GTCACAGTTTTCAGCTGTATAGGG -3′; 
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IL-10, forward, 5′-ATCGATTTCTCCCCTGTGAA-3′, and reverse, 
5′-TGTCAAATTCATTCATGGCCT-3′; TGF-β, forward, 
5′-GACCGCAACAACGCCATCTAT-3′, and reverse, 
5′-GGCGTATCAGTGGGGGTCAG-3′; Arginase-1, forward, 
5′-CAGAAGAATGGAAGAGTCAG-3′, and reverse, 
5′-CAGATATGCAGGGAGTCACC-3′; Ym-1, forward, 
5′-CAGGTCTGGCAATTCTTCTGAA-3′, and reverse, 
5′-GTCTTGCTCATGTGTGTAAGTGA-3′; Fizz-1, forward, 
5′-TCCCAGTGAATACTGATGAGA-3′, and reverse,  
5′-CCACTCTGGATCTCCCAAGA-3′; β-actin, forward, 
5′-GTGGGCCGCTCTAGGCACCA-3′, and reverse, 
5′-CGGTTGGCCTTAGGGTTCAGGGGG-3′. 
 
 
Confocal microscopy 
Frozen sections of adipose tissues were fixed using a cold acetone and methanol (1:1) 
mixture. Whole mounts of WAT were minced into small piece, fixed in 4% 
paraformaldehyde, permeabilized with 1% Triton X-100 (Thermo Scientific, Waltham, 
MA) for 1 h, and blocked with 5% goat serum. The frozen sections or whole adipose 
tissues were stained with Alexa® 488-conjugated anti-mouse F4/80 antibodies 
(eBiosceince). The nuclear DNA was stained with 4′,6-diamidino-2-phenylindole 
dihydrochloride (DAPI) (Molecular Probe Inc. Eugene, OR). The tissues were 
counterstained for 1 h with 5 µM BODIPY 558/568 
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C12[4,4-difluoro-5-(2-thienyl)-4-bora-3a, 4a-diaza-s-indacene-3-dodecanoic acid 
(Invitrogen, Carlsbad, CA) to visualize adipocytes. The images were acquired using an 
LSM 5 PASCAL Confocal Laser-scanning (Carl Zeiss, Jena, Germany). 
 
Oil Red O staining 
For staining of lipids, the frozen sections of salivary gland from WT and ArKO mice 
were fixed with 10% phosphate-buffered formaldehyde, incubated for 1 min in 60% 
2-propanol, stained for 15 min with Oil Red O solution (Sigma-Aldrich), rinsed in 60% 
2-propanol, and washed with water. The specimens were counterstained with Mayer’s 
hematoxylin solution for 5 min. 
 
Immunohistochemical analysis 
For immunohistochemical analysis of MCP-1 in salivary gland, paraffin-embedded 
sections were deparaffinized and subsequently applied to heat-induced antigen retrieval 
in 10 mM citrate buffer (pH 6.0). The sections were incubated with rabbit MCP-1 
polyclonal antibody (BioSS, Dundee Scotland) or control rabbit immunoglobulin and 
subsequently developed using horseradish-peroxidase-conjugated anti-rabbit 
immunoglobulin (Vector Laboratories Ltd., Peterborough, UK), and were 
counterstained with methyl green. 
 
Statistical analysis 
Statistical significance was determined using an unpaired the Student’s t test.       
Results 
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Inflammatory Lesions of Lacrimal and Salivary Glands in ArKO Mice 
ArKO mice spontaneously develop SS-like lesions in their lacrimal and salivary 
glands.15 In the present study, using another line of ArKO mice,17 lacrimal and salivary 
gland tissues were histopathologically analyzed until the mice reached 18 months of age. 
Severe inflammatory lesions with lymphocyte infiltration and tissue destruction in the 
lacrimal and salivary glands of ArKO mice were observed during the first 12 months, 
which resemble those of human SS (Figure 1A). Although slight or mild inflammation 
of the lacrimal and salivary glands was observed in wild-type (WT) mice older than 12 
months, severe inflammatory lesions significantly increased in ArKO mice of the same 
age (Figure 1B). A large number of CD4+ T cells as well as B220+ cells infiltrated the 
salivary glands of the ArKO mice (Supplemental Figure 1A). Moreover, significantly 
higher levels of autoantibodies such as anti-SSA, anti-SSB, and anti-ssDNA, were 
detected in the sera of ArKO mice compared with those in the sera of WT mice 
(Supplemental Figure 1B). These findings are consistent with the results of another 
study that demonstrated that hyperactivation of B cells contributes to the onset of 
SS-like autoimmune lesions in lacrimal and salivary glands of ArKO mice .15 
To determine the contribution of peripheral immune cells, including B cells, to the 
onset of autoimmunity in ArKO mice, 5 × 106 spleen cells from WT or ArKO mice were 
intravenously transferred into recombination activating gene 2 knockout (Rag2KO) 
mice. Twelve weeks after transfer, all organs were pathologically analyzed. Neither WT 
nor ArKO spleen cells induced inflammatory lesions in the lacrimal or salivary glands 
of the recipient mice (Figure 1C). Further, there were no differences in the serum levels 
of autoantibodies, including anti-SSA, anti-SSB, anti-α-fodrin, and anti-ssDNA (Figure 
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1D).9 Moreover, transfer of bone marrow cells from ArKO mice into irradiated Rag2KO 
mice could not induce inflammatory lesion in salivary glands (Supplemental Figure 2A). 
In addition, the serum level of autoantibodies of the recipient mice transplanted with 
bone marrow cells from ArKO mice was similar to that from WT mice (Supplemental 
Figure 2B). These findings suggest that the transfer of immune cells from ArKO mice 
failed to induce SS-like lesions in the target exocrine glands. Moreover, they suggest 
that other factors influence the onset or development of inflammatory lesion in ArKO 
mice. 
  
Relationship between Adipose Tissue and Immune Cells of ArKO Mice 
Aromatase is abundantly present in the adipose tissues,18 and the adipocytes of ArKO 
mice are significantly larger and more abundant compared with those of WT mice.14 
Furthermore, monocytes or cytokines in adipose tissue contribute to the pathogenesis of 
autoimmune disease.19,20 Therefore, we focused on adipose tissues to determine whether 
they were involved in inducing the SS-like lesions in ArKO mice. The volume of 
abdominal white adipose tissue (WAT) in female ArKO mice at 12 months of age was 
greater than that of WT mice (Figure 2A). There was a slight but insignificant increase 
in body weight of ArKO mice compared with WT mice. However, the weight of WAT of 
ArKO mice was significantly increased (Figure 2B). Moreover, flow cytometric analysis 
showed that the proportion of dendritic cells (DCs) and macrophages in the WAT of 
ArKO mice was higher than that of WT mice (Figure 2C) as well as the absolute 
numbers of DCs and macrophages (Figure 2D). These findings suggest that increased 
numbers of DCs and macrophages in WAT may influence the onset or development of 
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SS-like lesions. 
 
Expression of mRNAs Encoding Macrophage-Associated Proteins in WAT of ArKO 
Mice 
To understand the characteristics of macrophages that accumulated in the adipose 
tissues of ArKO mice, the expression levels of macrophage-associated genes were 
quantified using real-time reverse transcription polymerase chain reaction (RT-PCR). 
We detected significantly increased expression of mRNAs encoding cell surface 
glycoprotein F4/80 and monocyte chemotactic protein-1 (MCP-1) in the WAT of ArKO 
mice compared with WT mice (Figure 3A). The expression levels of mRNAs encoding 
Toll-like receptor-4 (TLR-4) and nuclear factor-κB (NF-κB) in ArKO mice were 
significantly higher than that in WT mice (Figure 3A). 
  Macrophage phenotypes are defined as M1 and M2 according to their production 
of certain cytokines.21 M1-macrophages produce the proinflammatory cytokines 
interleukin (IL)-1β, IL-6, interferon (IFN)-γ, and tumor necrosis factor (TNF)-α. In 
contrast, M2-macrophages produce the anti-inflammatory cytokines IL-10 and tumor 
growth factor (TGF)-β. The expression levels of mRNAs encoding IL-1β, IL-6, IFN-γ, 
and TNF-α mRNA in WAT of ArKO mice were significantly increased compared with 
that in WT mice (Figure 3B). In contrast, expression levels of mRNAs encoding IL-10 
and TGF-β mRNA of WAT in ArKO mice were significantly reduced (Figure 3B). In 
addition, there was no significant difference in mRNA expression of M2-macrophage 
markers such as Arginase-1, Fizz-1, and Ym-1 in WAT between WT and ArKO mice 
(Figure 3B). These findings suggest that aromatase regulates the migration and 
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differentiation of macrophages in adipose tissues as well as their subsequent activation. 
 
Macrophages in Adipose Tissues of ArKO Mice 
The distribution of macrophages in WAT was evaluated using immunofluorescence 
microscopy. Hematoxylin–eosin (HE) staining of adipose tissue sections revealed the 
accumulation of mononuclear cells around adipocytes in ArKO mice (Figure 4A). 
Moreover, the accumulated macrophages formed a crown-like structure in the WAT of 
ArKO mice; this was detected using DAPI (red) staining and an anti-F4/80 monoclonal 
antibody (green) (Figure 4A). Confocal microscopy revealed that accumlation of F4/80+ 
macrophages surrounding adipocytes stained with BODIPYR (blue) (Figure 4A). CCR2, 
a marker of M1-macrophages, was expressed at significantly higher levels by F4/80+ 
cells in the WAT of ArKO mice compared than in WT mice. In contrast, CD206, a 
marker of M2-macrophages, was expressed at significantly lower levels in the WAT of 
ArKO mice than in WT mice (Figure 4B). The results suggest that the increased 
abundance of WAT in ArKO mice enhanced the migration and maturation of activated 
M1-macrophages. 
 
Effect of an Aromatase Inhibitor on WAT and Salivary Glands 
MCP-1 produced by adipocytes or macrophages plays a key role in chemotaxis of 
monocytes into adipose tissues.22 However, it is unclear whether aromatase/estrogens 
regulate the expression of MCP-1 in WAT. To address this question, we intraperitoneally 
administered 0, 50, and 200 µg of aromatase inhibitor (AI) into female C57BL/6 mice 
daily for one week. Using real-time RT-PCR, we subsequently determined the 
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expression levels of Mcp-1 mRNA in various organs. The levels of the mRNA encoding 
MCP-1 in WAT increased as a function of AI dose (Figure 5). The expression of Mcp-1 
mRNA in the salivary gland, a target organ of SS, was enhanced by AI treatment, but 
not in the liver and spleen (Figure 5). These findings demonstrate that the expression of 
MCP-1 in the salivary glands as well as in WAT is regulated by aromatase/estrogens. 
 
Expression of MCP-1 in Salivary Glands and Cervical WAT 
Abundant adipose tissue surrounds the salivary gland, and a change in fat levels is often 
observed in atrophic salivary glands because of chronic inflammation or aging. When 
the fatty change of the salivary gland in ArKO mice was compared with that in WT 
mice using Oil red O staining, more salivary gland cells exhibited a fatty change in 
ArKO mice (Figure 6A). Moreover, the expression level of Mcp-1 mRNA of the 
salivary gland tissue of ArKO mice was significantly increased compared with that of 
WT mice (Figure 6B). A significantly increased number of F4/80+ macrophages in the 
cervical WAT around the salivary glands of ArKO mice were detected using 
immunofluorescence staining (Figure 6C). Further, the expression of MCP-1 in the 
salivary gland of ArKO mice was significantly increased compared with that of WT 
mice (Figure 6D). In addition, macrophage markers of salivary gland tissues were 
analyzed by real-time RT-PCR. TLR-4 mRNA of salivary gland from ArKO mice was 
significantly increased compared with that of WT mice (Supplemental Figure 3). There 
was no difference in mRNA expression such as IFN-γ, TNF-α, IL-10, and TGF-β in the 
salivary gland tissues between WT and ArKO mice (Supplemental Figure 3). The 
findings suggest that MCP-1 may play a key role in the development of SS-like lesions 
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in the salivary glands. 
 
Effect of AI Administration on Autoimmune Lesions in Mouse Model of Primary SS 
To confirm the role of aromatase in the SS-like lesions in the salivary and lacrimal 
glands, AI was administered into a model for SS which is thymectomized (Tx) NFS/sld 
mouse strain at three days after birth.23,24 AI (200 µg/mouse) was intraperitoneally 
administered into Tx NFS/sld mice daily from 4 to 8 weeks of age. The severity of 
autoimmune lesions in the lacrimal and salivary glands of Tx NFS/sld mice (8 weeks) 
was enhanced (Figure 7A). The inflammatory lesions of SS-model mice were markedly 
more severe compared with those of the control mice (Figure 7B). The proportion of 
CD11C+DCs and F4/80+ macrophages in the spleens of SS-model mice treated with AI 
was significantly higher compared with controls (Figure 7C, D). Further, the serum 
levels of anti-α-fodrin and anti-ssDNA antibodies of AI-treated SS-model mice were 
significantly higher compared with controls (Figure 7E). These findings suggest that 
imbalance of aromatase/estrogens may contribute to the onset or development of 
SS-like lesions through accumulated macrophages or DCs.      
 
Discussion 
Evidence indicates that the pathogenesis of autoimmune diseases, such as SS, is 
influenced by multiple factors.25 Most autoimmune diseases occur more frequently in 
women than men.3,4 In particular, various autoimmune diseases occur in 
postmenopausal women, who are over middle age around postmenopausal stage. 
Experimental and clinical evidence suggests that autoimmunity is influenced by several 
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differences in the immune responses between males and females.26,27 For example, Th1 
and Th2 responses are induced by androgens or estrogens, respectively.28,29 Among sex 
hormones, estrogens are the most potent modulator of the immune system, suggesting 
that a significant change in estrogen levels, such as those that occur during menopause, 
triggers autoimmunity.30 Aromatase catalyzes critical steps in the synthesis of 
estrogens.31 A number of studies demonstrate that ArKO mice provide an informative 
animal model for estrogen insufficiency in humans that facilitate our understanding of 
how estrogens influence the immune system.12,13,15 Therefore, in the present study, we 
used ArKO mice to determine whether there is a link between adipose tissue and the 
immune system with the hope of establishing the molecular basis of the development of 
autoimmunity. 
  Shim et al. reported that ArKO mice spontaneously develop SS-like autoimmune 
lesions through B cell hyperplasia and the production of autoantibodies.15 The report 
have demonstrated that estrogen administration into ArKO mice results in preventing 
SS-like lesions, suggesting that estrogen may play a key role in the pathogenesis of 
autoimmune lesions of ArKO mice.15 We also observed SS-like inflammatory lesions in 
lacrimal and salivary glands and increased autoantibody production by ArKO mice. 
Moreover, adoptive transfer of both spleen cells and bone marrow cells from ArKO 
mice into Rag2KO mice failed to induce inflammatory lesions, suggesting that in ArKO 
mice factors other than immune cells contribute to the pathogenesis of SS-like disease. 
On the other hand, serum concentration of estradiol of ArKO mice is baseline similar to 
that of WT mice in normal status.32 Although the estradiol or progesterone level of 
female WT mice is promoted in the estrus cycle, no change of the level is observed in 
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female ArKO mice.32 It is believed that hypotalamis-pituitary axis is disrupted in ArKO 
mice. Therefore, change of estrogen with diestrous/estrous phase of the cycle is not seen 
in ArKO mice. In addition, it was reported that prolactin and testosterone levels of the 
sera in female ArKO mice are significantly elevated compared with those of WT mice.33 
There may be any difference in the physiological function for immune response 
between estrogen and androgen. Previous reports demonstrated that administration of 
androgen protects autoimmune lesions in murine SS models.34,35 However, the function 
and metabolism of sex hormones are so complicated that the precise molecular 
mechanism of sex dimorphism in the onset of autoimmunity remains unclear. 
  It is well known that autoimmunity is multifactorial disease. Although lack of 
estrogen is important for the onset or development of autoimmunity, the other factors 
influence the pathogenesis of the autoimmune disease. For instance, when neonatally 
thymectomized NFS/sld mice, one of murine SS models, are ovariectomized during 
childbearing age, the autoimmune lesions are severely exaggerated.7 In the present 
paper, the incidence of autoimmune lesions in ArKO mice is largely increased after 6 
months of age, suggesting that aging or unknown factor may influence the onset or 
development of autoimmunity in the model. On the other hand, there is no report as for 
inflammatory lesions in estrogen receptor-α or -β knockout. It is believed that 
autoimmune disease is triggered by multiple factors. Although deficiency in 
estrogen/estrogen receptor signaling influences immune responses, only deficiency in 
the signaling cannot break the immune tolerance to induce autoimmunity. Aromatase 
may be related with various factors for the pathogenesis of SS-like lesions. However, 
further research based on sex steroid hormone will be required for understanding the 
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molecular pathogenesis of autoimmunity. 
  Aromatase is considerably expressed in adipose tissues, and ArKO mice develop 
marked abdominal adiposity, which is accompanied by increases in the weight of the 
gonadal and infrarenal fat pads.13,14 Adipose tissues in obesity disrupt the immune 
system and influence the pathogenesis of autoimmune disease.36,37 Therefore, we 
determined whether the presence of immune cells in adipose tissues plays a role in 
autoimmunity in ArKO mice. More important, similar to its effects on adipose tissue, 
we show that aromatase/estrogens control adiposity and the production of MCP-1 in the 
salivary gland, a target organ of SS. We speculate that salivary gland cells with 
adiposity controlled by aromatase may produce MCP-1 to attract macrophages to the 
target organ. Accumulated M1-macrophages might secrete inflammatory cytokines to 
enhance SS-like lesions and function as antigen-presenting cells in the target organ to 
develop SS-like lesions. These findings suggest that the specificity of the salivary gland 
as a target organ in SS may be explained by the estrogen deficiency-induced phenotypic 
change of salivary glands. 
  Excess adiposity increases the risk of developing metabolic syndrome,38 and 
obesity is a state of chronic systemic inflammation. Macrophages are considered a 
crucial component of adipose tissues involved in physiologic and pathologic 
remodeling.35 Monocytes are recruited to adipose tissues in obesity to become 
M1-macrophages and produce MCP-1, IL-1β, IL-6, IFN-γ, and TNF-α to promote 
systemic proinflammatory signaling.39,40 In contrast, M2-macrophages produce IL-10 
and TGF-β to suppress inflammation.39,40 Because IL-1β and TGF-β are enzymatically 
cleaved, the production of the tissues was measured by ELISA. Although IL-1β of 
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WAT from ArKO mice was significantly increased compared with that from WT mice 
(WT; 120.3 ± 39.2 pg/WAT, ArKO 191.3 ±52.3 pg/WAT, p<0.05), TGF-β was 
undetectable. It seems to be difficult to quantify the concentration of TGF-β in WAT. 
M1-macrophages contribute to increased insulin resistance in obesity, and 
M2-macrophages enhance insulin sensitivity through a PPARγ-dependent mechanism.22 
The development of obesity in ArKO mice occurs at three months of age and is 
accompanied by a marked increase in the weights of WAT, suggesting that estrogen 
synthesis regulates lipid metabolism.14 However, the report did not indicate whether the 
increased weight of WAT influences the immune system. In the present study, we report 
that the number of M1-macrophages in the WAT of ArKO mice increased compared 
with WT mice in addition to the increased WAT. Moreover, our findings suggest that the 
synthesis of MCP-1 by WAT plays a key role in attracting M1-macrophages to WAT, 
which induces the preferential production of proinflammatory cytokines. 
  The role of the aromatase–estrogen axis in the onset or development of 
autoimmune disease is poorly understood. DCs and macrophages, which are present in 
WAT and salivary glands, may play a key role in disrupting peripheral immune 
tolerance and trigger the onset or enhance the development of SS-like lesions. Increased 
adiposity in the salivary gland resembling that of the WAT in ArKO mice suggests that 
changes occur in the salivary glands in postmenopausal women with SS. Furthermore, 
fatty change is observed in the salivary glands of women with SS.41 Further, a clinical 
study observed that the expression of MCP-1 is significantly upregulated in salivary 
gland tissues from patients with SS compared with those from healthy controls.42 Our 
present findings suggest that in ArKO mice, adiposity in the salivary gland was due to 
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estrogen deficiency and further suggest the chain of events as follows: 1. MCP-1 
produced by the salivary gland and fat tissue attracted macrophages. 2. The production 
of several proinflammatory cytokines by these macrophages disrupted local immune 
tolerance in the salivary gland to trigger the onset of SS. Therefore, estrogen deficiency 
caused by menopause may link the pathogenesis of SS to an imbalance of cytokine 
production by macrophages in adipose and target tissues. In addition, our previous 
paper demonstrated estrogen deficiency triggers or promotes apoptosis of salivary gland 
cells.8 Our preliminary experiment showed that increased apoptotic cells were found in 
aged ArKO mice compared with WT mice. Therefore, it is possible that a part of 
salivary gland cells with adiposity would undergo apoptosis. Aromatase deficiency 
results in the low estrogen level or estrogen deficiency. Physiological change of 
estrogen in female is not observed in ArKO mice. We think that the normal change of 
estrogen in female through aromatase maintains physiological homeostasis in immune 
system, fat metabolism, and so on. As described in our paper, aging is also related with 
the pathogenesis of autoimmunity in ArKO mice. Although the precise molecular 
mechanism has not been unclear, aromatase may play the key role in the onset or 
development of SS-like lesions through disturbance of immune cells, adipose tissue, 
and target organ. 
     In conclusion, aromatase deficiency resulted in the onset and development of 
SS-like autoimmune lesions through a switch to cytokine production by 
M1-macrophages in systemic adipose tissues and target organs. Our findings suggest 
that decrease of estrogens induced by menopause plays a key role in the pathogenesis of 
autoimmunity.                     
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Figure Legends 
Figure 1 SS-like lesions in the lacrimal and salivary glands of ArKO mice. A: Severe 
inflammatory lesions in the lacrimal glands (LG) and salivary glands (SG) of ArKO 
mice. Shown are representative images of hematoxylin and eosin (HE)-stained sections 
of WT and ArKO mice 12 months of age. Scale bar: 200 µm. B: Pathological score of 
inflammatory lesions in LG (upper panel) and SG (lower panel) was evaluated using 
H&E-stained sections of female WT and ArKO mice from three to 18 months of age 
(WT, n = 19; ArKO, n = 19). C: 5 × 106 spleen cells from WT and ArKO were 
intravenously transferred into female Rag2KO mice at 8 weeks of age. Pathological 
analysis of the LG and SG of the recipient Rag2KO mice was performed three months 
after transfer. Images are representative of each recipient group (n = 5). D: 
Autoantibody production (anti-SSA, anti-SSB, anti-ssDNA, and anti-α-fodrin 
antibodies) in the sera of recipient Rag2KO mice was analyzed using ELISAs. Data are 
shown as the average ± standard deviation (SD) of five mice of each group. 
 
Figure 2 Adipose tissues of ArKO mice. A: Representative images of WAT of WT and 
ArKO mice 12 months of age are shown. The lower panel shows formalin-fixed tissues. 
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Scale bar: 1 cm. B: Body weight and WAT weight of WT and ArKO mice were 
measured at 12 months of age. Data represent the average ± SD of five mice from each 
group. **p < 0.005. C: The proportion of CD11c+F4/80−DCs or F4/80+ macrophages in 
WAT of WT and ArKO mice was analyzed using flow cytometry. Results are 
representative of five mice from each group. D: The number of DCs and macrophages 
in WAT of WT and ArKO mice 12 months of age was evaluated. Cell number is shown 
as the average ± SD of five mice of each group. *p < 0.05, **p < 0.005. 
 
Figure 3 Real-time reverse transcription polymerase chain reaction of the expression of 
monocyte-related genes in ArKO and WT mice. (A) Levels of mRNAs encoding F4/80, 
MCP-1, TLR-4, and NF-κB in WAT of WT and ArKO mice 12 months of age. (B) The 
levels of mRNAs encoding IL-1β, IL-6, IFN-γ, TNF-α, IL-10, TGF-β, Arginase-1, 
Fizz-1, and Ym-1 in WAT of WT and ArKO mice. Data represent the average ± SD of 
five mice from each group. *p < 0.05, **p < 0.005. 
 
Figure 4 Macrophages infiltrating the WAT of ArKO mice. A: H&E-staining of WAT is 
shown in the upper panel. F4/80+ macrophages in WAT of WT and ArKO mice were 
detected using immunofluorescence staining. Adipocytes were stained with BODIPYR, 
and F4/80+ macrophages in the WAT were detected using a confocal microscope. Nuclei 
were stained with DAPI. Images represent three mice of each group. DAPI color is 
shown in red. Images represent three mice from each group. Scale bar: 50 µm. B: Flow 
cytometric analysis of CCR2 and CD206 expression on F4/80+ macrophages in the 
WAT of WT and ArKO mice. Results represent three mice from each group. The gray 
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line indicates the data for the isotype control. The number of F4/80 positive cells/ mm2 
was counted. Data represent the average ± SD of five mice from each group. *p < 0.05, 
**p < 0.005. 
 
Figure 5 Effect of AI on the expression of Mcp-1 mRNA in various tissues. Daily 
peritoneal injections of AI (0, 50, and 200 µg/mouse) were administered to female B6 
mice 10 weeks of age for a week. The expression of Mcp-1 mRNA in WAT, salivary 
glands, liver, and spleen was analyzed using real-time RT-PCR. Data represent the 
average ± SD of 5 mice of each group. *p < 0.05, **p < 0.005. 
 
Figure 6 Relationship between fatty change and the expression of Mcp-1 in the salivary 
glands of ArKO mice. A: Frozen sections of salivary glands in WT and ArKO mice at 
10 months of age were stained with Oil Red O. Original magnification: 100× (upper 
panel, scale bar: 100 µm), 400× (lower panel, scale bar: 20 µm). Images represent three 
mice from each group. B: The expression of Mcp-1 mRNA in salivary glands of WT 
and ArKO mice was analyzed using real-time RT-PCR. Data represent the average ± SD 
of three mice from each group. **p < 0.005. C: F4/80+ macrophages in the adipose 
tissue around salivary glands of WT and ArKO mice were detected using 
immunofluorescence staining. Nuclei were stained with DAPI. Scale bar: 50 µm. The 
number of F4/80 positive cells/ mm2 was counted. Data represent the average ± SD of 
five mice from each group. *p < 0.05. D: MCP-1+ cells in the salivary glands of WT 
and ArKO mice were detected using immunohistochemical analysis. Nuclei were 
stained with methyl green. Scale bar: 20 µm. 
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Figure 7 Effect of AI on the autoimmune lesions in SS-model mice. A: AI (200 µg) 
dissolved in CMC was peritoneally injected daily into female Tx-NFS/sld mice 4–8 
weeks of age. Control Tx-NFS/sld mice were injected with CMC. Pathology of lacrimal 
and salivary glands was determined using HE staining. Photos are representative of five 
mice from each group. Original magnification: 200×. Scale bar: 100 µm. B: 
Pathological grading was evaluated using HE-stained sections. Data represent the 
average ± SD of five mice from each group. *p < 0.05. C: The proportion of monocytes 
that expressed CD11c and F4/80 was analyzed using flow cytometry. Results are 
representative of five mice from each group. D: CD11c+DCs and F4/80+ macrophages 
were quantified using flow cytometric analysis. Data represent the average ± standard 
deviation (SD) of five mice from each group. *p < 0.05. E: Serum levels of anti-SSA, 
anti-SSB, anti-α-fodrin and anti-ssDNA antibodies were determined using ELISAs. 
Data represent the average ± SD of five mice from each group. *p < 0.05. 
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